Study directory

Mental health studies with practical context.

Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.

Back to overview
108studies shown
Showing 101-108 of 108
CompletedNCT03345342

A Study of Paliperidone Palmitate 6-Month Formulation

This study exists to explore whether the medication Paliperidone could improve care and understanding. Researchers are trying to understand whether the medication Paliperidone can better prevent setbacks and support longer-term stability.

SchizophreniaOtherFrom 18 Years to 70 Years
Countries
Argentina, Australia, Brazil, Bulgaria, Czech Republic, France, China, Hungary, India, Italy, Malaysia, Mexico, Poland, Russian Federation, South Africa, South Korea, Spain, Taiwan, Turkey, Ukraine, United States
Sponsor
Janssen Research & Development, LLC
Condition
Schizophrenia
CompletedNCT01051531

A Safety, Tolerability, and Treatment Response Study of Paliperidone Palmitate Administered to Patients With Schizophrenia

This study exists to better understand the safety of the medication Paliperidone and how manageable it feels in practice. Researchers are trying to understand whether the medication Paliperidone can better prevent setbacks and support longer-term stability.

SchizophreniaOtherFrom 18 Years to 50 Years
Countries
Australia, China, Malaysia, New Zealand, Philippines, South Korea, Taiwan, Thailand
Sponsor
Janssen Research & Development, LLC
Condition
Schizophrenia
CompletedNCT03859973

This Study Tests Whether BI 425809 Together With Brain Training Using a Computer Improves Mental Functioning in Patients With Schizophrenia

This study exists to compare options and see whether a medication treatment offers something meaningfully different. Researchers are trying to understand what a medication treatment can reveal about signals in the brain or body that may guide care later on.

SchizophreniaOtherFrom 18 Years to 50 Years
Countries
Australia, Canada, France, New Zealand, United Kingdom, United States
Sponsor
Boehringer Ingelheim
Condition
Schizophrenia
CompletedNCT05253417

The CANabidiol Use for RElief of Short Term Insomnia

This study exists to compare options and see whether a digital app or remote support tool offers something meaningfully different. Researchers are trying to understand whether a digital app or remote support tool can improve sleep, daily rhythms, and longer-term stability.

AnxietyOtherFrom 18 Years to 65 Years
Countries
Australia
Sponsor
Bod Australia
Condition
Anxiety
TerminatedNCT02827513

A Phase 1 Study to Investigate the Safety, Tolerance, Food Effect, Pharmacokinetics and Pharmacodynamics of Single and Multiple Doses of Extended Release Formulations of Centanafadine (CTN) in Young Healthy Subjects

This study exists to better understand the safety of a medication treatment and how manageable it feels in practice. Researchers are trying to understand how people respond to a medication treatment in practice and what may need to be adjusted.

ADHDOtherFrom 18 Years to 45 Years
Countries
Australia
Sponsor
Otsuka Pharmaceutical Development & Commercialization, Inc.
Condition
ADHD
CompletedNCT04866030

Drug Use Study With Intuniv® in Australia

This study exists to explore whether questionnaires and follow-up reports could improve care and understanding. Researchers are trying to understand what questionnaires and follow-up reports could change in day-to-day care and decision-making.

ADHDOtherFrom 6 Years to 17 Years
Countries
Australia
Sponsor
Shire
Condition
ADHD
TerminatedISRCTN00982930

The shareIT project

This public ISRCTN record appears to relate to depression. HopeStage keeps this listing available so people can review the official source, understand the basic study status, and decide what questions to ask before contacting the research team.

DepressionOtherOver 18 Years
Countries
Australia
Sponsor
Australian National University (Australia)
Condition
Depression